- Report
- June 2024
- 125 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- April 2025
- 182 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- June 2024
- 200 Pages
Global
From €7261EUR$7,950USD£6,209GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1370EUR$1,500USD£1,172GBP
- Report
- May 2023
- 160 Pages
Global
From €4520EUR$4,949USD£3,865GBP
- Report
- July 2024
- 77 Pages
Global
From €3500EUR$4,105USD£3,098GBP
The Periodontal Therapeutics market is a subset of the Dental industry, focusing on the treatment of periodontal diseases. These diseases are caused by bacteria that accumulate in the gums and can lead to tooth loss and other serious health issues. Treatment options include antibiotics, antiseptics, and other medications, as well as surgical procedures. The market is driven by the increasing prevalence of periodontal diseases, as well as the growing awareness of the importance of oral health.
The market is highly competitive, with a number of companies offering products and services. These include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other players in the market include Sunstar, Colgate-Palmolive, and Procter & Gamble. Show Less Read more